Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artificial Intelligence
Biotech
Recursion streamlines pipeline following merger with Exscientia
Evidently in the mood for spring cleaning, Recursion is clearing out part of its pipeline as it narrows its focus on oncology and rare diseases.
Fraiser Kansteiner
May 5, 2025 11:00am
Roche nets FDA breakthrough label for AI lung cancer CDx test
Apr 29, 2025 2:07pm
Study illustrates pros, cons of AI readings in 3D mammography
Apr 25, 2025 12:00pm
Etiome emerges with $50M from Flagship, plans to preempt disease
Apr 24, 2025 6:00am
Bayer boosts precision oncology efforts with multiyear AI deal
Apr 23, 2025 12:55pm
Tempus AI in line for $200M from AstraZeneca cancer model deal
Apr 23, 2025 9:01am
